Author

Alejandro M. Sevillano

The University of Texas MD Anderson Cancer CenterORCID 0000-0002-2107-2375Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Ayşegül ŞahiniD· 1 shared Ehsan IrajizadiD· 1 shared Elizve Barrientos-ToroiD· 1 shared Fu Chung Hsiao· 1 shared Hiroyuki KatayamaiD· 1 shared Jennifer B. DennisoniD· 1 shared Jody Vykoukal· 1 shared Johannes Francois FahrmanniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ayşegül ŞahinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Aberrant expression of CD14 in breast tumor cells is associated with poor outcome

Hiroyuki Katayama, Rongzhang Dou, Ricardo A. Léon-Letelier, Ehsan Irajizad, Alejandro M. Sevillano, So‐Young Park, Fu Chung Hsiao, Yining Cai, Jody Vykoukal, Johannes Francois Fahrmann, Jennifer B. Dennison, Elizve Barrientos-Toro, Maria Gabriela Raso, Ayşegül Şahin, Samir Hanash

This study identifies aberrant CD14 expression in breast tumor cells as a marker of poor clinical outcomes and aggressive disease.

bioRxiv · Nov 7, 2024 · PreprintCancer Biology